Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25138217 | 0.86 | ADORA3 (0.36) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL23765624 | 0.83 | MEN1 (0.31) | LMNASMN1; SMN2 | |
| SCHEMBL23059121 | 0.82 | ADORA3 (0.36) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL23059124 | 0.75 | KDM4E (0.39) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL22147810 | 0.72 | KDM4E (0.38) | LMNA | |
| SCHEMBL26275270 | 0.72 | KDM4E (0.47) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL32662296 | 0.72 | KDM4E (0.47) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL16722857 | 0.72 | KDM4E (0.47) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL16709181 | 0.68 | ADORA3 (0.36) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 | |
| SCHEMBL16709180 | 0.68 | KDM4E (0.39) | ADORA3ADORA2AADORA1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230118772-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118772-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, LIG1, AP1M1 | ADORA3 4650/4885ADORA2A 4631/4885ADORA1 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.